Oversubscribed £2.5M seed round led by Ahren Innovation Capital Strategic collaboration with o2h to progress drug discovery programme OutSee, a genomics and drug discovery company pioneering a unique ...

OutSee, announced the closure of its £2.5M seed funding round. The Company also announced the signing of a strategic agreement with o2h discovery, a preclinical Contract Research Organisation with an ...

The MarketWatch News Department was not involved in the creation of this content. -- Oversubscribed GBP2.5M seed round led by Ahren Innovation Capital -- Strategic collaboration with o2h to progress ...

CAMBRIDGE, England--(BUSINESS WIRE)--OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its ...